BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Covington
McKesson
Johnson and Johnson
Medtronic
AstraZeneca
Healthtrust
Merck
US Army
Fish and Richardson

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016818

« Back to Dashboard

NDA 016818 describes EMETE-CON, which is a drug marketed by Pfizer and Roerig and is included in two NDAs. Additional details are available on the EMETE-CON profile page.

The generic ingredient in EMETE-CON is benzquinamide hydrochloride. Additional details are available on the benzquinamide hydrochloride profile page.
Summary for 016818
Tradename:EMETE-CON
Applicant:Roerig
Ingredient:benzquinamide hydrochloride
Patents:0

Profile for product number 006

Active Rx/OTC/Discontinued:DISCNDosage:SUPPOSITORY;RECTALStrengthEQ 100MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
US Department of Justice
Teva
Healthtrust
QuintilesIMS
Argus Health
Fuji
Cantor Fitzgerald
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot